François Ducray
- Genetics top 0.1%
- Glioma Diagnosis and Treatment 144
- Neurology top 0.5%
- Autoimmune Neurological Disorders and Treatments 29
- Neuroblastoma Research and Treatments 17
- Peripheral Neuropathies and Disorders 15
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism 19
-
- Brain Metastases and Treatment 40
- Structural Biology top 5%
-
- Meningioma and schwannoma management 38
-
- Radiomics and Machine Learning in Medical Imaging 19
- Co-authors
- Jean‐Yves DelattreAhmed IdbaïhKhê Hoang‐XuanJérôme HonnoratKarima MokhtariDamien RicardMarc SansonM. Lahutte
- Cited by
- GeneticsNeurologyCancer Research
- Journals
- Neuro-Oncology (24 papers)Journal of Neuro-Oncology (17 papers)Journal of Clinical Oncology (13 papers)
- Partner nations
- FranceItalyUnited States
In The Last Decade
François Ducray
193 papers receiving 6.2k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Genetics 3.5k
- Neurology 2.1k
- Cancer Research 1.2k
- Pulmonary and Respiratory Medicine 1.3k
- Structural Biology 53
Countries citing papers authored by François Ducray
This map shows the geographic impact of François Ducray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Ducray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Ducray more than expected).
Fields of papers citing papers by François Ducray
This network shows the impact of papers produced by François Ducray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Ducray. The network helps show where François Ducray may publish in the future.
Co-authorship network
The 25 scholars most cited alongside François Ducray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2022 | 4 | |
| 4 | 2021 | 6 | |
| 5 | 2021 | 0 | |
| 6 | 2021 | 5 | |
| 7 | 2021 | 47 | |
| 8 | 2020 | 30 | |
| 9 | 2020 | 44 | |
| 10 | 2020 | 58 | |
| 11 | 2019 | 8 | |
| 12 | 2018 | 25 | |
| 13 | 2017 | 56 | |
| 14 | 2015 | 37 | |
| 15 | 2014 | 37 | |
| 16 | 2012 | 99 | |
| 17 | 2012 | 84 | |
| 18 | 2011 | 160 | |
| 19 | Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomasbreakdown → | 2009 | 773 |
| 20 | 2006 | 43 |
About François Ducray
François Ducray is a scholar working on Genetics, Neurology, Structural Biology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 206 papers that have together received 6.3k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (144 papers), Brain Metastases and Treatment (40 papers), Meningioma and schwannoma management (38 papers), Autoimmune Neurological Disorders and Treatments (29 papers), Radiomics and Machine Learning in Medical Imaging (19 papers), Cancer, Hypoxia, and Metabolism (19 papers), Neuroblastoma Research and Treatments (17 papers) and Peripheral Neuropathies and Disorders (15 papers). The work is most often cited by research in Genetics (3.5k citations), Neurology (2.1k citations), Cancer Research (1.2k citations), Pulmonary and Respiratory Medicine (1.3k citations) and Structural Biology (53 citations). François Ducray has collaborated with scholars based in France, Italy and United States. Frequent co-authors include Jean‐Yves Delattre, Ahmed Idbaïh, Khê Hoang‐Xuan, Jérôme Honnorat, Karima Mokhtari, Damien Ricard, Marc Sanson, M. Lahutte, Véronique Rogemond and Yannick Marie. Their work appears in journals such as Neuro-Oncology, Journal of Neuro-Oncology, Journal of Clinical Oncology, Neurology and Journal of Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.